BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Leukemia AND HRAS, K-ras, 3265, ENSG00000174775, HRAS1, RASH1, c-bas/has, P01112, N-ras AND Prognosis
54 results:

  • 1. [Clinical Characteristics and prognosis of Acute Myeloid leukemia Patients with inv(16)/t(16;16)(p13.1;q22) and/or CBFβ-MYH11].
    Wang YM; Cai P; Zhou MJ; Gong YY; Pan JL; Cen JN; Yang XF; Chen SN
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Apr; 30(2):. PubMed ID: 35400360
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. [Clinical Characteristics and prognosis of Acute Myeloid leukemia Patients with inv(16)/t(16;16)(p13.1;q22) and/or CBFβ-MYH11].
    Wang YM; Cai P; Zhou MJ; Gong YY; Pan JL; Cen JN; Yang XF; Chen SN
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Apr; 30(2):367-372. PubMed ID: 35395965
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Optimized outcome prediction of oncogenetic mutations in non-early T-cell precursor acute lymphoblastic leukemia.
    Peng LJ; Wang SS; Guo SS; Zhang JJ; Liu YF; Rousseaux S; Khochbin S; Chen B; Wang J; Mi JQ
    Immunobiology; 2022 May; 227(3):152205. PubMed ID: 35279479
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Rapid Detection of n-ras Gene Common Mutations in Acute Myeloid leukemia (AML) Using High Resolution Melting (HRM) Method.
    Zaka Khosravi S; Moonesi M; Moradabadi A; Rajaeinejad M; Heidari MF; Noroozi-Aghideh A
    Asian Pac J Cancer Prev; 2022 Jan; 23(1):125-130. PubMed ID: 35092380
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. [Clinical Characteristics of Acute Myeloid leukemia Patients with RUNX1 Gene Mutation].
    Ni ZF; Ma LJ; Shi LL; Shen PL; Zhao JQ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Oct; 29(5):1411-1416. PubMed ID: 34627418
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. [Clinical Analysis of Gene Mutation in Adult Patients with B-ALL and Its Influence on Clinical prognosis].
    Deng M; Zuo WL; Zhang CL; Wei XD; Li XY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Dec; 28(6):1867-1872. PubMed ID: 33283712
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. [Analysis of Gene Mutation and Clinical Characteristics in 19 Children with Juvenile Myelomonocytic leukemia].
    Weng KZ; Zheng YZ; Zhuang SQ; Chen HY; LE SH
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Dec; 28(6):1811-1818. PubMed ID: 33283703
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. [Clinical analysis of 12 cases of acute myeloid leukemia complicated with synchronous primary solid tumor].
    Mi RH; Dang HB; Chen L; Han YL; Wang MF; Zhang YL; Chen L; Li DB; Wei XD
    Zhonghua Yi Xue Za Zhi; 2020 Nov; 100(42):3323-3327. PubMed ID: 33202495
    [No Abstract]    [Full Text] [Related]  

  • 9. [Clinical Significance of Common Gene Mutations in 53 Patients with Acute Myeloid leukemia Harboring 11q23/MLL Rearrangements].
    Bai SX; Gong YL; Zhang JR; Wu CX; Zhang J; Qiu HY; Shen HJ; Cen JN; Chen SN; Pan JL
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Jun; 28(3):717-723. PubMed ID: 32552926
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Nuclear factor of activated T-cells, NFATC1, governs FLT3
    Solovey M; Wang Y; Michel C; Metzeler KH; Herold T; Göthert JR; Ellenrieder V; Hessmann E; Gattenlöhner S; Neubauer A; Pavlinic D; Benes V; Rupp O; Burchert A
    J Hematol Oncol; 2019 Jul; 12(1):72. PubMed ID: 31286998
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Inhibition of MEK and ATR is effective in a B-cell acute lymphoblastic leukemia model driven by
    Chu SH; Song EJ; Chabon JR; Minehart J; Matovina CN; Makofske JL; Frank ES; Ross K; Koche RP; Feng Z; Xu H; Krivtsov A; Nussenzweig A; Armstrong SA
    Blood Adv; 2018 Oct; 2(19):2478-2490. PubMed ID: 30266823
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. [Genetic abnormalities in core binding factor acute myeloid leukemia].
    Ishikawa Y
    Rinsho Ketsueki; 2017; 58(8):991-998. PubMed ID: 28883285
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Targeting the kinase activities of ATR and ATM exhibits antitumoral activity in mouse models of MLL-rearranged AML.
    Morgado-Palacin I; Day A; Murga M; Lafarga V; Anton ME; Tubbs A; Chen HT; Ergan A; Anderson R; Bhandoola A; Pike KG; Barlaam B; Cadogan E; Wang X; Pierce AJ; Hubbard C; Armstrong SA; Nussenzweig A; Fernandez-Capetillo O
    Sci Signal; 2016 Sep; 9(445):ra91. PubMed ID: 27625305
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Acute lymphoblastic leukemia in the context of RASopathies.
    Cavé H; Caye A; Strullu M; Aladjidi N; Vignal C; Ferster A; Méchinaud F; Domenech C; Pierri F; Contet A; Cacheux V; Irving J; Kratz C; Clavel J; Verloes A
    Eur J Med Genet; 2016 Mar; 59(3):173-8. PubMed ID: 26855057
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Genetic mutational profiling analysis of T cell acute lymphoblastic leukemia reveal mutant FBXW7 as a prognostic indicator for inferior survival.
    Yuan L; Lu L; Yang Y; Sun H; Chen X; Huang Y; Wang X; Zou L; Bao L
    Ann Hematol; 2015 Nov; 94(11):1817-28. PubMed ID: 26341754
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Mutations of Epigenetic Modifier Genes as a Poor Prognostic Factor in Acute Promyelocytic leukemia Under Treatment With All-Trans Retinoic Acid and Arsenic Trioxide.
    Shen Y; Fu YK; Zhu YM; Lou YJ; Gu ZH; Shi JY; Chen B; Chen C; Zhu HH; Hu J; Zhao WL; Mi JQ; Chen L; Zhu HM; Shen ZX; Jin J; Wang ZY; Li JM; Chen Z; Chen SJ
    EBioMedicine; 2015 Jun; 2(6):563-71. PubMed ID: 26285909
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. The impact of SF3B1 mutations in CLL on the DNA-damage response.
    Te Raa GD; Derks IA; Navrkalova V; Skowronska A; Moerland PD; van Laar J; Oldreive C; Monsuur H; Trbusek M; Malcikova J; Lodén M; Geisler CH; Hüllein J; Jethwa A; Zenz T; Pospisilova S; Stankovic T; van Oers MH; Kater AP; Eldering E
    Leukemia; 2015 May; 29(5):1133-42. PubMed ID: 25371178
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. STAT3 supports experimental k-rasG12D-induced murine myeloproliferative neoplasms dependent on serine phosphorylation.
    Gough DJ; Marié IJ; Lobry C; Aifantis I; Levy DE
    Blood; 2014 Oct; 124(14):2252-61. PubMed ID: 25150294
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Gene mutation patterns in patients with minimally differentiated acute myeloid leukemia.
    Kao HW; Liang DC; Wu JH; Kuo MC; Wang PN; Yang CP; Shih YS; Lin TH; Huang YH; Shih LY
    Neoplasia; 2014 Jun; 16(6):481-8. PubMed ID: 25022553
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Methylation of CTNNA1 promoter: frequent but not an adverse prognostic factor in acute myeloid leukemia.
    Chen XX; Lin J; Qian J; Qian W; Yang J; Ma JC; Deng ZQ; An C; Tang CY; Qian Z; Liu Q
    Leuk Res; 2014 May; 38(5):613-8. PubMed ID: 24685333
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 3.